Amy L. Jonson

1.1k total citations
17 papers, 851 citations indexed

About

Amy L. Jonson is a scholar working on Surgery, Oncology and Reproductive Medicine. According to data from OpenAlex, Amy L. Jonson has authored 17 papers receiving a total of 851 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Surgery, 6 papers in Oncology and 6 papers in Reproductive Medicine. Recurrent topics in Amy L. Jonson's work include Ovarian cancer diagnosis and treatment (6 papers), Testicular diseases and treatments (3 papers) and Intraperitoneal and Appendiceal Malignancies (3 papers). Amy L. Jonson is often cited by papers focused on Ovarian cancer diagnosis and treatment (6 papers), Testicular diseases and treatments (3 papers) and Intraperitoneal and Appendiceal Malignancies (3 papers). Amy L. Jonson collaborates with scholars based in United States, Sweden and Canada. Amy L. Jonson's co-authors include Levi S. Downs, Peter A. Argenta, Patricia L. Judson, Linda F. Carson, Melissa A. Geller, Rahel Ghebre, Robin Bliss, Kathryn E. Dusenbery, Lana Bijelić and Paul H. Sugarbaker and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Annals of Oncology.

In The Last Decade

Amy L. Jonson

17 papers receiving 829 citations

Peers

Countries citing papers authored by Amy L. Jonson

Since Specialization

Citations

This map shows the geographic impact of Amy L. Jonson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy L. Jonson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy L. Jonson more than expected).

Fields of papers citing papers by Amy L. Jonson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy L. Jonson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy L. Jonson. The network helps show where Amy L. Jonson may publish in the future.

Co-authorship network of co-authors of Amy L. Jonson

This figure shows the co-authorship network connecting the top 25 collaborators of Amy L. Jonson. A scholar is included among the top collaborators of Amy L. Jonson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy L. Jonson. Amy L. Jonson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Hyperthermic intraperitoneal chemotherapy with carboplatin for optimally-cytoreduced, recurrent, platinum-sensitive ovarian carcinoma: A pilot study 2013 ·Gynecologic Oncology ·Peter A. Argenta, Thanasak Sueblinvong, Melissa A. Geller, Amy L. Jonson, Levi S. Downs, Linda F. Carson, Joseph J. Ivy, Patricia L. Judson	25
2	A phase II trial of carboplatin and docetaxel followed by radiotherapy given in a “Sandwich” method for stage III, IV, and recurrent endometrial cancer 2011 ·Gynecologic Oncology ·Melissa A. Geller, Joseph J. Ivy, Rahel Ghebre, Levi S. Downs, Patricia L. Judson, Linda F. Carson, Amy L. Jonson, Kathryn E. Dusenbery, Rachel I. Vogel, Matthew Boente, Peter A. Argenta	46
3	Idiopathic Adrenal Hemorrhage in a Patient with Gestational Trophoblastic Neoplasia 2011 ·Journal of Gynecologic Surgery ·Jori S. Carter, (unknown), Amy L. Jonson	2
4	A phase I study of lenalidomide in combination with liposomal doxorubicin in recurrent epithelial ovarian cancer. 2011 ·Journal of Clinical Oncology ·(unknown), Melissa A. Geller, Patricia L. Judson, Peter A. Argenta, Rahel Ghebre, Amy L. Jonson, (unknown), Levi S. Downs	2
5	A prospective, randomized trial of integrative medicine for women with ovarian cancer 2011 ·Gynecologic Oncology ·Patricia L. Judson, Elizabeth L. Dickson, Peter A. Argenta, Yin Xiong, Melissa A. Geller, Linda F. Carson, Rahel Ghebre, Amy L. Jonson, Levi S. Downs	8
6	Learning about ovarian cancer at the time of diagnosis: Video versus usual care 2010 ·Gynecologic Oncology ·Melissa A. Geller, Levi S. Downs, Patricia L. Judson, Rahel Ghebre, Peter A. Argenta, Linda F. Carson, Amy L. Jonson, (unknown), Rachel I. Vogel, (unknown)	17
7	Gonadal Dysgenesis and Gynecologic Cancer 2010 ·Obstetrics and Gynecology ·Amy L. Jonson, Melissa A. Geller, Elizabeth L. Dickson	23
8	A phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast cancer 2010 ·Cytotherapy ·Melissa A. Geller, Sarah Cooley, Patricia L. Judson, Rahel Ghebre, Linda F. Carson, Peter A. Argenta, Amy L. Jonson, Angela Panoskaltsis‐Mortari, Julie Curtsinger, David H. McKenna, Kathryn E. Dusenbery, Robin Bliss, Levi S. Downs, Jeffrey S. Miller	355
9	Outcomes associated with different intraperitoneal chemotherapy delivery systems in advanced ovarian carcinoma: A single institution's experience 2009 ·Gynecologic Oncology ·Joseph J. Ivy, Melissa A. Geller, (unknown), Amy L. Jonson, Peter A. Argenta	8
10	A phase II study of fulvestrant in the treatment of multiply-recurrent epithelial ovarian cancer 2009 ·Gynecologic Oncology ·Peter A. Argenta, (unknown), Patricia L. Judson, Levi S. Downs, Melissa A. Geller, Linda F. Carson, Amy L. Jonson, Rahel Ghebre	74
11	Gene silencing with siRNA targeting E6/E7 as a therapeutic intervention in a mouse model of cervical cancer 2008 ·Gynecologic Oncology ·Amy L. Jonson, Lisa M. Rogers, Sundaram Ramakrishnan, Levi S. Downs	49
12	Phase II trial of fulvestrant in the treatment of recurrent ovarian carcinoma 2008 ·Gynecologic Oncology ·(unknown), Patricia L. Judson, Linda F. Carson, Levi S. Downs, Rahel Ghebre, Melissa A. Geller, Amy L. Jonson, Peter A. Argenta	1
13	Systematic review of cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis in primary and recurrent ovarian cancer 2007 ·Annals of Oncology ·Lana Bijelić, Amy L. Jonson, Paul H. Sugarbaker	96
14	Phase I trial combining gemcitabine and treosulfan in advanced cutaneous and uveal melanoma patients 2005 ·British Journal of Cancer ·Pippa Corrie, John M. Shaw, Victoria J. Spanswick, (unknown), Amy L. Jonson, A Mayer, (unknown), John A. Hartley, Ian A. Cree	28
15	Clinical features and outcomes of uterine and ovarian carcinosarcoma 2005 ·Gynecologic Oncology ·Amy L. Jonson, Robin Bliss, Alexander M. Truskinovsky, Patricia L. Judson, Peter A. Argenta, Linda F. Carson, Kathryn E. Dusenbery, Levi S. Downs	40
16	A prospective, randomized study analyzing sartorius transposition following inguinal–femoral lymphadenectomy 2004 ·Gynecologic Oncology ·Patricia L. Judson, Amy L. Jonson, Pamela J. Paley, Robin Bliss, (unknown), Levi S. Downs, Matthew Boente, Peter A. Argenta, Linda F. Carson	59
17	Disease activity and need for dental care in a capitation plan based on risk assessment 2000 ·BDJ ·Ingegerd Zickert, Amy L. Jonson, (unknown), B Krasse	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact